Management of tumor lysis syndrome with standard continuous arteriovenous hemodialysis: Case report and a review of the literature

Renal Failure

Volumn 20, Issue 4, 1998, Pages 635-644

  Schelling, Jeffrey R ^a,b   Ghandour, Fadi Z ^a   Strickland, Theodore J ^b   Sedor, John R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Continuous arteriovenous hemodialysis; Non Hodgkin's lymphoma; Tumor lysis syndrome

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CRITICAL ILLNESS; DIALYSATE; DISEASE COURSE; EXTRACELLULAR SPACE; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYPOTENSION; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 0031823230     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045157     Document Type: Article

References (32)

1. Pichette V, Leblanc M, Bonnardeaux A, Ouimet D, Geadah D, Cardinal J: High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome. Am J Kidney Dis 23:591-596, 1994.
2. Hande KR, Garrow GC: Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Am J Med 94:133-139, 1993.
3. Arrambide K, Toto RD: Tumor lysis syndrome. Sem Nephrol 13:273-280, 1993.
4. Cohen LF, Balow JE, Magath IT, Poplack DG, Ziegler JL: Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med 68:486-491, 1980.
5. Tsokos GC, Balow JE, Spiegel RJ, Magrath IT: Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine 60:218-229, 1981.
6. Weinman EJ, Eknoyan G, Suki WN: The influence of the extracellular fluid volume on the tubular reabsorption of uric acid. J Clin Invest 55:283-291, 1975.
7. Bone RC: Immunologic dissonance: a continuing evolution in our underrating of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Int Med 125:680-687, 1996.
8. Conger JD, Falk SA, Guggenheim SJ, Burke TJ: A micropuncture study of the early study of acute urate nephropathy. J Clin Invest 58:681-689, 1976.
9. Spencer HW, Yarger WE, Robinson RR: Alterations of renal function during dietary -induced hyperuricemia in the rat. Kidney Int 9:489-500, 1976.
10. Ablin A, Stephens BG, Hirata T, Wilson K, Williams HE: Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinol. Metabolism 21:771-778, 1972.
11. Band PR, Silverberg DS, Henderson JF, Ulan RA, Wensel RH, Banerjee, TK, Little AS: Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Eng J Med 283:354-357, 1970.
12. Andreoli SP, Clark JH, McGuire WA, Bergstein JM: Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure. J Pediatr 109:292-298, 1986.
13. Cadman EC, Lunberg WB, Bertino JR: Hyperphosphatemia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's lymphoma and Burkitt cell leukemia. Am J Med 62:283-290, 1977.
14. Boles JM, Dutel JL, Briere J, Mialon P, Robasckiewicz M, Garre M: Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia. Cancer 53:2425-2429, 1984.
15. Mitnick PD, Goldfarb S, Slatapolsky E, Lemann J, Jr., Gray RW, Agus ZS: Calcium and phosphate metabolism in tumoral calcinosis. Ann Int Med 92:482-487, 1980.
16. Shackney S, Hasson J: Precipitous fall in serum calcium, hypotension and acute renal failure after intravenous phosphate therapy for hypercalcemia. Report of two cases. Ann Int Med 66:906-916, 1967.
17. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664, 1987.
18. Schelling JR, Sodor JR: Influence of cytokines on the renal circulation and nephron function. In: C Ronco, R Bellomo, eds: Critical Care in Nephrology. Dortrecht, Kluwer, 1997, in press.
19. Minasian LM, Szatrowski TP, Rosenblum M, Steffens T, Morrison ME, Williams L, Nathan CF, Houghton AN: Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-alpha and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma. Blood 83:56-61, 1994.
20. Conger JD, Schultz MF, Miller F, Robinette JB: Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 46:318-323, 1994.
21. Kjellstrand CM, Campbell DC, von Hartitzsch B, Buselmeier TJ: Hyperuricemic acute renal failure. Arch Int Med 133:349-359, 1974.
22. Kohen JA, Whitley KY, Kjellstrand CM: Continuous arteriovenous hemofiltration: a comparison with hemodialysis in acute renal failure. Trans-ASAIO 31:169-175, 1985.
23. Kierdorf HP, Sieberth HG: Continuous renal replacement therapies versus intermittent hemodialysis in acute renal failure: what do we know? Am J Kidney 28:S90-S96, 1996.
24. van Bommel E, Bouvy ND, So KL, Zietse R, Vincent HH, Bruining HA, Weimar W: Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol 15:192-200, 1995.
25. Simpson K, Allison MEM: Dialysis and acute renal failure: can mortality be unproved? Nephrol Dial Transpl 8:946, 1993.
26. Mehta R, McDonald B, Gabbai F, Pahl M, Farkas A, Pascual M, Fowler W: Continuous versus intermittent dialysis for acute renal failure in the ICU: results from a randomized multicenter trial. J Am Soc Nephrol 7:1457, 1996.
27. Stevens PE, Rainford DJ: Isovolemic hemodialysis combined with hemofiltration in acute renal failure. Renal Failure 12:203-211, 1990.
28. Heney D, Essex-Cater A, Brockbank JT, Bailey CC, Lewis IJ: Continuous arteriovenous haemofiltration in the treatment of tumor lysis syndrome. Ped Nephrol 4:245-247, 1990.
29. Bishof NA, Welch TR, Strife CF, Ryckman FC: Continuous hemodiafiltration in children. Pediatrics 83:819-823, 1990.
30. Smoyer WE, McAdams C, Kaplan BS, Sherbotie JR: Determinants of survival in pediatric continuous hemofiltration. J Am Soc Nephrol 6:1401-1409, 1995.
31. Saccente SL, Kohaut EC, Berkow RL: Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration. Ped Nephrol 9:569-573, 1995.
32. Sakarcan A, Quigley R: Hyperphosphatemia in tumor lysis syndrome: the role of hemodialysis and continuous veno-venous hemofiltration. Ped Nephrol 8:351-353, 1994.